Tong-chong Zhou
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial.
Journal: BMJ (Clinical research ed.)
Published: April 15, 2025
Predictive value of CXCL1+_FAP+ phenotype in CAFs for distant metastasis and its correlation with PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma patients.
Journal: Oral oncology
Published: April 12, 2024
Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutation.
Journal: BMC research notes
Published: November 26, 2021
Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery.
Journal: Radiation oncology (London, England)
Published: November 12, 2018
Extraskeletal osteosarcoma in right neck subcutaneous tissue: A case report of an extremely rare tumour.
Journal: Molecular and clinical oncology
Published: December 11, 2017
ShRNA-mediated silencing of the ubiquitin-specific protease 22 gene restrained cell progression and affected the Akt pathway in nasopharyngeal carcinoma.
Journal: Cancer biology & therapy
Published: December 09, 2014
High expression of p300 is linked to aggressive features and poor prognosis of nasopharyngeal carcinoma.
Journal: Journal of translational medicine
Published: January 15, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026